DocDollars

Aesculap Biologics, LLC

PA · United States · Reporting entity ID 100000005660

Total reported 2019–2025
$7.10M
#594 of 2,960 reporting companies — 0% of all reported industry payments
$125K in general payments across 414 records, plus $6.97M in research funding across 1,158 records.

How it breaks down

General payments $125,456
Research funding $6,973,338

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Aesculap Biologics, LLC reported $7.10M to US doctors and teaching hospitals from 2019 to 2025, ranking #594 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 414 general payment records and 1,158 research records were filed.

Common questions about Aesculap Biologics, LLC

How much has Aesculap Biologics, LLC paid US doctors?

Aesculap Biologics, LLC reported $7,098,793 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $125,456 in general payments, $6,973,338 in research funding.

How does Aesculap Biologics, LLC rank among drug and device companies?

It ranks #594 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Aesculap Biologics, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.